Neuroprotective Properties of 4-Aminopyridine
As an antagonist of voltage-gated potassium (Kv) channels, 4-aminopyridine (4-AP) is used as symptomatic therapy in several neurologic disorders. The improvement of visual function and…
As an antagonist of voltage-gated potassium (Kv) channels, 4-aminopyridine (4-AP) is used as symptomatic therapy in several neurologic disorders. The improvement of visual function and…
Objective Therapies targeting B cells have been used in the clinic for multiple sclerosis (MS). In patients with relapsing MS, anti-CD20 therapy often suppresses relapse…
. Read article in journal’s website
. Read article in journal’s website
Case A 77-year-old man had a 1-day history of acute dysphagia to both solid and liquid, requiring nasogastric feeding. Thirty minutes after the dysphagia started…
We present the case of a 68-year-old woman who developed progressive visuospatial deficits in a period of 18 months, leading to the loss of her…
The late astronomer Carl Sagan once said that “extraordinary claims require extraordinary evidence.” Read article at journal’s website
A 4-year-old girl, the first child of nonconsanguineous parents, with normal motor development, presented with frequent falls, difficulty getting up from the floor, and muscle…
In their case report, Dr. Méndez-Guerrero and colleagues add to the growing literature suggesting the neuroinvasive potential and neurologic sequelae of infection with the novel…
Objective To determine whether the Alzheimer disease (AD) dementia conversion-related pattern (ADCRP) on [18F]FDG PET can serve as a valid predictor for the development of…